Stoke Therapeutics Inc (STOK)
$26.29 -0.23% Close Oct 30, 2026 Live
Stoke Therapeutics stock today
Stoke Therapeutics closed at $26.29 on October 30, 2026, down 0.23% on the day. Over the past year it returned -17.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.64 billion.
$25.00$30.00$35.00
NovJan 2026MarMayJulSep
| Period | STOK | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.1% | -0.9% |
| 3 months | -12.5% | +2.1% |
| Year to date | -17.2% | +11.7% |
| 1 year | -17.1% | +12.4% |
| 3 years | +636.4% | +88.5% |
| 5 years | +15.2% | +76.0% |
Key statistics
- Market value
- $1.64B
- Price / sales
- 59.3
- 52-week range
- $22.37 to $38.35
About Stoke Therapeutics
Develops gene therapy treatments for genetic disorders affecting the nervous system.
Sector: Health Care
More on Stoke Therapeutics
- Financials: revenue, earnings and segmentsRevenue +405% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $1,152 today
No forecast, no recommendation. This page describes Stoke Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.